Emile-Victor Kuyl

Emile-Victor Kuyl

Auto-generated profile, based on publicly available information

Emile-Victor Kuyl

Department of Orthopaedic Surgery, School of Medicine and Health Sciences, George Washington University, Washington

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in The Bone & Joint Journal
Verified
Journal Article
Closed access
PDF file
EKEmile-Victor Kuyl
Emile-Victor Kuyl
FSFei Shu
Fei Shu
BSBranden Sosa
Branden Sosa
JLJuan D. Lopez
Juan D. Lopez
DQDi Qin
Di Qin
XYXu Yang
Xu Yang
Aims: Aseptic loosening is a leading cause of uncemented arthroplasty failure, often accompanied by fibrotic tissue at the bone-implant interface. A biological target, neutrophil extracellular traps (NETs), was investigated as a crucial connection between the innate immune system’s response to injury, fibrotic tissue development, and proper bone healing. Prevalence of NETs in peri-implant fibrotic tissue from aseptic loosening patients was assessed. A murine model of osseointegration failure was used to test the hypothesis that inhibition (through Pad4-/- mice that display defects in peptidyl arginine deiminase 4 (PAD4), an essential protein required for NETs) or resolution (via DNase 1 treatment, an enzyme that degrades the cytotoxic DNA matrix) of NETs can prevent osseointegration failure and formation of peri-implant fibrotic tissue. Methods: Patient peri-implant fibrotic tissue was analyzed for NETs biomarkers. To enhance osseointegration in loose implant conditions, an innate immune system pathway (NETs) was either inhibited ( Pad4-/- mice) or resolved with a pharmacological agent (DNase 1) in a murine model of osseointegration failure. Results: NETs biomarkers were identified in peri-implant fibrotic tissue collected from aseptic loosening patients and at the bone-implant interface in a murine model of osseointegration failure. Inhibition ( Pad4-/- ) or resolution (DNase 1) of NETs improved osseointegration and reduced fibrotic tissue despite loose implant conditions in mice. Conclusion: This study identifies a biological target (NETs) for potential noninvasive treatments of aseptic loosening by discovering a novel connection between the innate immune system and post-injury bone remodelling caused by implant loosening. By inhibiting or resolving NETs in an osseointegration failure murine model, fibrotic tissue encapsulation around an implant is reduced and osseointegration is enhanced, despite loose implant conditions. Cite this article: Bone Joint J 2021;103-B(7 Supple B):135–144.

14 January 2024 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
AZAmy Y. Zhao
Amy Y. Zhao
EKEmile-Victor Kuyl
Emile-Victor Kuyl
AAAmil R. Agarwal
Amil R. Agarwal
ADAvilash Das
Avilash Das
AHAndrew Harris
Andrew Harris
GGGregory J. Golladay
Gregory J. Golladay

1 May 2022 in Bone & Joint Research
Verified
Journal Article
Open access
KSKevin Staats
Kevin Staats
BSBranden Sosa
Branden Sosa
EKEmile-Victor Kuyl
Emile-Victor Kuyl
FWFei Wang
Fei Wang
VSVincentius Suhardi
Vincentius Suhardi
XYXu Yang
Xu Yang
Aims: To develop an early implant instability murine model and explore the use of intermittent parathyroid hormone (iPTH) treatment for initially unstable implants. Methods: 3D-printed titanium implants were inserted into an oversized drill-hole in the tibiae of C57Bl/6 mice (n = 54). After implantation, the mice were randomly divided into three treatment groups (phosphate buffered saline (PBS)-control, iPTH, and delayed iPTH). Radiological analysis, micro-CT (µCT), and biomechanical pull-out testing were performed to assess implant loosening, bone formation, and osseointegration. Peri-implant tissue formation and cellular composition were evaluated by histology. Results: iPTH reduced radiological signs of loosening and led to an increase in peri-implant bone formation over the course of four weeks (timepoints: one week, two weeks, and four weeks). Observational histological analysis shows that iPTH prohibits the progression of fibrosis. Delaying iPTH treatment until after onset of peri-implant fibrosis still resulted in enhanced osseointegration and implant stability. Despite initial instability, iPTH increased the mean pull-out strength of the implant from 8.41 N (SD 8.15) in the PBS-control group to 21.49 N (SD 10.45) and 23.68 N (SD 8.99) in the immediate and delayed iPTH groups, respectively. Immediate and delayed iPTH increased mean peri-implant bone volume fraction (BV/TV) to 0.46 (SD 0.07) and 0.34 (SD 0.10), respectively, compared to PBS-control mean BV/TV of 0.23 (SD 0.03) (PBS-control vs immediate iPTH, p < 0.001; PBS-control vs delayed iPTH, p = 0.048; immediate iPTH vs delayed iPTH, p = 0.111). Conclusion: iPTH treatment mediated successful osseointegration and increased bone mechanical strength, despite initial implant instability. Clinically, this suggests that initially unstable implants may be osseointegrated with iPTH treatment. Cite this article: Bone Joint Res 2022;11(5):260–269.

10 November 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
EKEmile-Victor Kuyl
Emile-Victor Kuyl
AAAmil R. Agarwal
Amil R. Agarwal
PPParth K. Patel
Parth K. Patel
AHAndrew Harris
Andrew Harris
AGAlex Gu
Alex Gu
GGGregory J. Golladay
Gregory J. Golladay

12 November 2024 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
PPPhilip M. Parel
Philip M. Parel
EKEmile-Victor Kuyl
Emile-Victor Kuyl
MHMark Haft
Mark Haft
RSRachel Silverman
Rachel Silverman
ARAbhisri Ramesh
Abhisri Ramesh
USUma Srikumaran
Uma Srikumaran

26 September 2023 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
AIAnna M. Ifarraguerri
Anna M. Ifarraguerri
TQTheodore Quan
Theodore Quan
BFBenjamin Farley
Benjamin Farley
EKEmile-Victor Kuyl
Emile-Victor Kuyl
JKJohn Koch
John Koch
STSean Tabaie
Sean Tabaie